Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02611479 · ClinicalTrials.gov registry record

Understanding Non-Response in Spine Fusion Surgery

A clinical trial of Spine Fusion, sponsored by University of Washington.

Completed
Registry status
184
Enrollment target
4
Study locations

NCT02611479: Completed study of Spine Fusion, sponsored by University of Washington.

NCT02611479 is a study of Spine Fusion that has completed, run by University of Washington. The registered enrollment target is 184 participants, above the 107-participant average among 6 other Spine Fusion trials with a reported enrollment target (72% higher). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02611479, a study of Spine Fusion, has completed, sponsored by University of Washington.

COMPLETED
Registry status
184 participants
Enrollment target
4
Study locations

Study Summary

To identify patient characteristics associated with non-response after spine fusion surgery for the treatment of degenerative disc disease (DDD).

Primary Outcome

Change in pain and function after spine fusion surgery was measured by the Oswestry Disability Index. Scores range from 0 to 100. The questionnaire has 10 questions about pain intensity, personal care, lifting ability, walking ability, sitting ability, standing ability, sleeping ability, sex ability, social life, and travelling. Each question is followed by 6 options which describe the amount of disability a patient may face in these situations and the patient marks the statement most applicabl

Conditions Studied

Study Locations (4)

Washington

  • University of Washington - Seattle
  • Proliance Surgeons - Seattle
  • Swedish Medical Center - Seattle
  • Confluence Health - Wenatchee

Trial Details

FieldValue
Enrollment Target 184 participants
Start Date 2015-04
Est. Completion 2018-06
University of Washington

1,048 total trials

What the finished NCT02611479 record still lists

NCT02611479 is an observational study that tracks outcomes without assigning an intervention. The registered 184 participants enrollment target is mid-sized for trials with a published cap, above the 107-participant average among 6 other Spine Fusion trials with a reported enrollment target (72% higher).

The record links to 1 condition, with Spine Fusion appearing as the primary indexed condition, and to 0 interventions.

NCT02611479 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02611479 about?

NCT02611479 is a clinical study titled "Understanding Non-Response in Spine Fusion Surgery". To identify patient characteristics associated with non-response after spine fusion surgery for the treatment of degenerative disc disease (DDD).

What is the current status of trial NCT02611479?

This trial is currently completed. The enrollment target is 184 participants. The study started on 2015-04. Estimated completion is 2018-06.

What conditions does trial NCT02611479 study?

This clinical trial studies the following conditions: Spine Fusion.

Who is sponsoring clinical trial NCT02611479?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02611479 being conducted?

This trial has 4 study locations across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spine Fusion

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03903510 · 184 participants · NA

    Virtual Reality During Pediatric Cast Removal

  • NCT04020510 · 184 participants · Phase 4

    Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder

  • NCT04135846 · 184 participants · Phase 2

    Alpha-1 Blockade for Alcohol Use Disorder (AUD)

  • NCT04396873 · 184 participants · Phase 1

    PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02611479, the US trial registry maintained by the National Library of Medicine. NCT02611479 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.